FDA
-
-
-
-
-
-
-
MIMEDX Announces Record Revenue for Third Quarter 2025
-
-
-
-
-
-
-
EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRO
-
-
-
-
-
-
-
MiMedx Group (MDXG) Provides Update on AXIOFILL Request for Designation from FDA
-
-
-
-
-
-
-
MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study
-
-
-
-
-
-
-
MIMEDX Addresses Presentation by Prescience Point
-
-
-
-
-
-
-
MIMEDX Outlines Key Strategic Milestones for 2022
-
-
-
-
-
-
-
MIMEDX Announces Collaborative Agreement with the Wake Forest Institute for Regenerative Medicine
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

